You are here:     > Corporate Overview > Board of Directors

Board of Directors

Mr. Glenn SaldanhaChairman & Managing Director

Mr. Saldanha joined Glenmark in 1998 as Director and took over as Managing Director & CEO in 2000. He transformed Glenmark into a truly global organisation with revenue over a billion dollar. Under his leadership, Glenmark has evolved from an Indian branded generics business into a research-driven and innovation-led organisation. Mr. Saldanha’s vision is to discover, develop and take to market India's first innovative drug for the entire world.

Mrs. Cherylann PintoDirector – Corporate Affairs

Mrs. Pinto is the Director of Corporate Affairs at Glenmark since October 1999 and is an executive member of the Board. With over 28 years of experience in the pharmaceutical field, she currently heads the Company’s Corporate Communications, Corporate Affairs, IT, Admin, HR and CSR functions. She had set up a pharmaceutical company where she served as the Managing Director from 1989 to 1999 before joining Glenmark.

Mr. V. S. ManiExecutive Director and Global CFO

Mr. Mani leads the organisation’s worldwide finance operations and secretarial function, including global accounting, financial reporting, tax and treasury. He has over 25 years of rich industry experience across treasury, taxation, accounting, financial planning & analysis, secretarial, legal, audits, risk management and investor relations. Prior to joining Glenmark in 2017, he was the President Finance at the Bhartiya Group. He has also held the position of the Chief Financial Officer at Cipla.

Mr. Rajesh V. DesaiNon-Executive Director

Mr. Desai is a Non-Executive Director at Glenmark Pharmaceuticals Ltd. He has over 34 years of work experience and was the Executive Director and Chief Financial Officer of Glenmark till 2016. He led the Finance, Legal and IT functions and with his strong Finance background, he contributed significantly to the growth story of Glenmark.

Dr. Brian W. TempestNon-Executive Director - Independent

Dr. Tempest has been working with the pharmaceutical industry for the last four decades and has managed healthcare businesses in North America, South America, Europe, Africa, the Middle East, Australasia, China, Japan and India. He is the editor of the Journal of Generic Medicines. He is also a Non-Executive Director on the Governance Board of the United Nations Patent Pool.

Mr. Bernard MunosNon-Executive Director - Independent

Mr. Munos advises organisations on being better innovators. He serves on the advisory council of the National Centre for Advancing Translational Sciences (NCATS); is a member of the National Academy of Medicine’s Forum on Drug R&D and Translation; an advisor to the journal Science Translational Medicine. His research on pharmaceutical innovation has been published in Nature and Science, as well as profiled by Forbes magazine.

Mrs. B. E. SaldanhaNon-Executive Director

Mrs. Saldanha is a Non-Executive Director and a member of the promoter group of Glenmark. Prior to this, she was the Director for exports and managed Glenmark’s international operations from 1982 to 2005. During her 23-year tenure with the organisation, she was responsible for developing and growing the Company’s export business.

Mr. Julio RibeiroNon-Executive Director - Independent

Mr. Ribeiro is a retired Indian police officer and civil servant and has held increasingly responsible positions during his career. Some of the noteworthy positions include the Commissioner of Police, Mumbai; Special Secretary to the Government of India, Ministry of Home Affairs; Director General of Police, Punjab; Advisor to the Governor of Punjab, and Ambassador of India to Romania. He currently serves as the Director of VVF Ltd.

Mr. Sridhar GorthiNon-Executive Director - Independent

Mr. Gorthi is a partner in the Mumbai office of Trilegal and his areas of expertise include M&A, joint ventures, private equity and venture capital. He has been actively involved in several high-profile cross-border transactions. Apart from representing several international clients on M&A in India, he has also advised Indian companies about outbound M&A transactions in jurisdiction such as the UK, the US, South Africa, Argentina, Indonesia and Sri Lanka.

Mr. Milind SarwateNon-Executive Director - Independent

Mr. Sarwate is the Founder and CEO of Increate Value Advisors LLP, a firm that facilitates organisations and individuals to discover, develop and deliver business and social value. He has over 32 years of experience in Finance, HR and Strategy in groups such as Marico and Godrej.

Mr. D. R. MehtaNon-Executive Director - Independent

Mr. Mehta was a civil servant for almost four decades and has experience in administration and management of public affairs. He joined the IAS in 1961 and has held positions in the Government of Rajasthan and in the Government of India. He has served as the Chairman of SEBI, the Deputy Governor of the RBI and the Director General of Foreign Trade, Ministry of Commerce, Government of India.